ClinConnect ClinConnect Logo
Search / Trial NCT07045363

Embedded Community-based Heart-Age Risk Education Trial in Cinese Primary Healthcare

Launched by DUKE KUNSHAN UNIVERSITY · Jun 27, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Heart Age Health Education

ClinConnect Summary

This study is looking at a new way to help older adults in China who have high blood pressure (also called hypertension) better understand their heart health. During regular doctor visits, patients will receive a simple, personalized report called a “Heart Age” that shows their heart risk based on their recent health check results. The goal is to see if this quick and easy information helps people become more aware of their heart health and encourages them to take better care of themselves, all without making doctor visits longer or more complicated.

To join the study, you need to be 60 years or older, have high blood pressure, have had a government-funded health check within the last three months, and be scheduled for a regular follow-up visit with your doctor. People with severe memory problems, serious illnesses that limit life expectancy, or those already in another clinical study cannot join. If you participate, your doctor will share your personalized Heart Age report during your usual appointment, and you’ll be asked about how this information affects your understanding and management of your heart health. This study is currently looking for volunteers who meet these criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged ≥60 years
  • Diagnosed with hypertension
  • Completed their government-funded annual health check within the past 3 months
  • Scheduled for a routine follow-up consultation within the enrollment window -Able to provide informed consent-
  • Exclusion Criteria:
  • Diagnosed dementia or severe cognitive impairment
  • Terminal illness
  • Participation in another clinical intervention trial

About Duke Kunshan University

Duke Kunshan University (DKU) is a prestigious international institution located in Kunshan, China, that combines the academic rigor of Duke University with a global perspective. As a sponsor of clinical trials, DKU is committed to advancing healthcare research through innovative studies that address pressing medical challenges. The university fosters collaboration among interdisciplinary teams, leveraging cutting-edge technology and methodologies to enhance clinical outcomes. With a focus on ethical research practices and community engagement, DKU aims to contribute significantly to the understanding and treatment of various health conditions, ultimately improving patient care and public health on a global scale.

Locations

Suzhou, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Guanzhou Wang

Principal Investigator

Duke University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported